Fukoku Mutual Life Insurance’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,339
| Closed | -$255K | – | 256 |
|
|
2025
Q3 | $255K | Hold |
1,339
| – | – | 0.02% | 207 |
|
|
2025
Q2 | $241K | Hold |
1,339
| – | – | 0.02% | 227 |
|
|
2025
Q1 | $227K | Hold |
1,339
| – | – | 0.02% | 245 |
|
|
2024
Q4 | $202K | Hold |
1,339
| – | – | 0.01% | 264 |
|
|
2024
Q3 | $208K | Buy |
+1,339
| New | +$200K | 0.01% | 264 |
|
|
2023
Q1 | – | Sell |
-3,070
| Closed | -$480K | – | 261 |
|
|
2022
Q4 | $480K | Buy |
3,070
+1,300
| +73% | +$187K | 0.04% | 124 |
|
|
2022
Q3 | $217K | Sell |
1,770
-220
| -11% | -$29K | 0.02% | 242 |
|
|
2022
Q2 | $265K | Hold |
1,990
| – | – | 0.02% | 222 |
|
|
2022
Q1 | $272K | Hold |
1,990
| – | – | 0.02% | 246 |
|
|
2021
Q4 | $344K | Sell |
1,990
-30
| -1% | -$4.57K | 0.03% | 214 |
|
|
2021
Q3 | $294K | Buy |
2,020
+320
| +19% | +$46.8K | 0.02% | 235 |
|
|
2021
Q2 | $224K | Hold |
1,700
| – | – | 0.02% | 257 |
|
|
2021
Q1 | $218K | Sell |
1,700
-200
| -11% | -$24.6K | 0.02% | 230 |
|
|
2020
Q4 | $226K | Sell |
1,900
-400
| -17% | -$48.8K | 0.02% | 218 |
|
|
2020
Q3 | $263K | Hold |
2,300
| – | – | 0.03% | 183 |
|
|
2020
Q2 | $262K | Hold |
2,300
| – | – | 0.03% | 174 |
|
|
2020
Q1 | $185K | Hold |
2,300
| – | – | 0.03% | 182 |
|
|
2019
Q4 | $246K | Buy |
2,300
+800
| +53% | +$83.4K | 0.03% | 213 |
|
|
2019
Q3 | $161K | Hold |
1,500
| – | – | 0.02% | 235 |
|
|
2019
Q2 | $153K | Sell |
1,500
-400
| -21% | -$38.4K | 0.02% | 235 |
|
|
2019
Q1 | $171K | Hold |
1,900
| – | – | 0.02% | 209 |
|
|
2018
Q4 | $158K | Hold |
1,900
| – | – | 0.02% | 206 |
|
|
2018
Q3 | $205K | Sell |
1,900
-300
| -14% | -$32.9K | 0.03% | 204 |
|
|
2018
Q2 | $242K | Hold |
2,200
| – | – | 0.03% | 170 |
|
|
2018
Q1 | $221K | Hold |
2,200
| – | – | 0.03% | 178 |
|
|
2017
Q4 | $217K | Hold |
2,200
| – | – | 0.03% | 191 |
|
|
2017
Q3 | $206K | Hold |
2,200
| – | – | 0.03% | 201 |
|
|
2017
Q2 | $245K | Hold |
2,200
| – | – | 0.04% | 173 |
|
|
2017
Q1 | $216K | Hold |
2,200
| – | – | 0.04% | 163 |
|
|
2016
Q4 | $202K | Hold |
2,200
| – | – | 0.03% | 176 |
|
|
2016
Q3 | $186K | Hold |
2,200
| – | – | 0.03% | 185 |
|
|
2016
Q2 | $179K | Sell |
2,200
-200
| -8% | -$15.2K | 0.04% | 186 |
|
|
2016
Q1 | $171K | Buy |
2,400
+300
| +14% | +$20.1K | 0.04% | 203 |
|
|
2015
Q4 | $149K | Buy |
2,100
+900
| +75% | +$60.5K | 0.03% | 240 |
|
|
2015
Q3 | $74K | Buy |
+1,200
| New | +$83.9K | 0.01% | 286 |
|
Other funds holding DGX
Fukoku Mutual Life Insurance's DGX Position: Q4 2025 in Review
Fukoku Mutual Life Insurance sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 1,339 shares — an estimated $255K sold.
Fukoku Mutual Life Insurance first reported a position in DGX in Q3 2015 and held it in 35 quarters. The position peaked at $480K in Q4 2022. 1,049 funds tracked by Wall St. Rank hold DGX as of Q4 2025.
- Fukoku Mutual Life Insurance reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
- Fukoku Mutual Life Insurance sold 1,339 Quest Diagnostics shares in Q4 2025, an estimated $255K.
- Fukoku Mutual Life Insurance first reported a position in Quest Diagnostics in Q3 2015 and held it in 35 quarters.
- Fukoku Mutual Life Insurance's Quest Diagnostics position peaked at $480K in Q4 2022.
- 1,049 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.
Based on Fukoku Mutual Life Insurance's 13F filing for Q4 2025, filed 10 Feb 2026.